Advertisement

Topics

GSK seeks FDA approval for expanded use of asthma drug Nucala

05:04 EDT 29 Jun 2017 | SmartBrief

A supplemental biologics application was submitted by GlaxoSmithKline to the FDA for Nucala, or mepolizumab, to be used with  -More

Original Article: GSK seeks FDA approval for expanded use of asthma drug Nucala

NEXT ARTICLE

More From BioPortfolio on "GSK seeks FDA approval for expanded use of asthma drug Nucala"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...